📰 Corbius Pharmaceutical News
Corbius Pharmaceutical News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Corbius Pharmaceutical. Real-time updates on events, politics, business and more.
May 3, 2023
The recent FDA approval of sarilumab for the treatment of refractory polymyalgia rheumatica may have a significant and lasting impact on the use of long-term steroids for that condition.
December 1, 2022
PHILADELPHIA — Patients with steroid-resistant polymyalgia rheumatica who received sarilumab and tapered glucocorticoids achieved higher remission rates vs. glucocorticoid taper alone, according to data presented at ACR Convergence 2022.